- Ticker iNav Bloomberg: IVEUREUR
- Exchange ticker: VEUR
- Bloomberg: VEUR IM
- ISIN: IE00B945VV12
- MEX ID: VIEURV
- Reuters: VEUR.MI
- SEDOL: BGSF280
The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.
As at 28 lut 2026
Please note Beta and R-squared data will only display for funds with 3 full years of history.
The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.
| Fundamentals | Fund | Benchmark | As at |
|---|---|---|---|
| Number of stocks | 527 | 505 | 28 lut 2026 |
| Median market capital | 78,3 B | 78,3 B | 28 lut 2026 |
| 18,3 x | 18,3 x | 28 lut 2026 | |
| 2,5 x | 2,5 x | 28 lut 2026 | |
| 14,2% | 14,2% | 28 lut 2026 | |
| 15,0% | 15,0% | 28 lut 2026 | |
| Portfolio turnover rate | -18,4% | — | 31 gru 2025 |
As at 28 lut 2026
| Country | Region | Fund | Benchmark | Variance +/- |
|---|---|---|---|---|
| Wielka Brytania | Europa | 23,39% | 23,24% | 0,15% |
| Szwajcaria | Europa | 14,81% | 14,84% | -0,03% |
| Francja | Europa | 14,46% | 15,41% | -0,95% |
| Niemcy | Europa | 13,79% | 13,81% | -0,02% |
| Holandia | Europa | 7,65% | 7,66% | -0,01% |
| Hiszpania | Europa | 5,74% | 5,75% | -0,01% |
| Szwecja | Europa | 5,40% | 5,42% | -0,02% |
| Włochy | Europa | 5,19% | 5,19% | 0,00% |
| Dania | Europa | 2,27% | 2,28% | -0,01% |
| Finlandia | Europa | 1,73% | 1,74% | -0,01% |
| Belgia | Europa | 1,68% | 1,68% | 0,00% |
| Norwegia | Europa | 0,94% | 0,95% | -0,01% |
| Inne | 0,93% | 0,00% | 0,93% | |
| Polska | Europa | 0,71% | 0,71% | 0,00% |
| Irlandia | Europa | 0,51% | 0,51% | 0,00% |
As at 28 lut 2026
| Holding name | % of market value | Sector | Region | Market value | Shares |
|---|---|---|---|---|---|
| ASML Holding NV | 3,75236% | Technology | NL | 265 670 659,80 € | 215 397 |
| Roche Holding AG | 2,19521% | Health Care | CH | 155 422 742,75 € | 384 541 |
| Novartis AG | 2,13242% | Health Care | CH | 150 977 710,39 € | 1 050 501 |
| HSBC Holdings PLC | 2,10585% | Financials | GB | 149 095 960,91 € | 9 395 560 |
| AstraZeneca PLC | 2,05025% | Health Care | GB | 145 159 514,40 € | 820 226 |
| Nestle SA | 1,80859% | Consumer Staples | CH | 128 049 942,77 € | 1 384 515 |
| Shell PLC | 1,56410% | Energy | GB | 110 740 112,17 € | 3 164 220 |
| Siemens AG | 1,40425% | Industrials | DE | 99 422 143,20 € | 401 868 |
| SAP SE | 1,35857% | Technology | DE | 96 187 737,68 € | 562 633 |
| Banco Santander SA | 1,23665% | Financials | ES | 87 556 199,51 € | 8 114 569 |
-
Inception date
21 maj 2013
Listing date
18 sty 2019
| Date | NAV (EUR) | Market price (EUR) |
|---|---|---|
| 02 kwi 2026 | 46,0675 € | 46,1850 € |
| 01 kwi 2026 | 46,1367 € | 46,1700 € |
| 31 mar 2026 | 45,0055 € | 45,1000 € |
| 30 mar 2026 | 44,8205 € | 44,8300 € |
| 27 mar 2026 | 44,3954 € | 44,4600 € |
| 26 mar 2026 | 44,7898 € | 44,8050 € |
| 25 mar 2026 | 45,2860 € | 45,3000 € |
| 24 mar 2026 | 44,6377 € | 44,7050 € |
| 23 mar 2026 | 44,4346 € | 44,5550 € |
| 20 mar 2026 | 44,1530 € | 44,2200 € |
Distribution frequency
Quarterly
Historical performance 28 lut 2026
2,61%
| Type | Distribution amount (per unit) | Ex-dividend date | Registration date | Payable date |
|---|---|---|---|---|
| Income | 0,1815 € | 19 mar 2026 | 20 mar 2026 | 01 kwi 2026 |
| Income | 0,1676 € | 18 gru 2025 | 19 gru 2025 | 31 gru 2025 |
| Income | 0,1609 € | 18 wrz 2025 | 19 wrz 2025 | 01 paź 2025 |
| Income | 0,7630 € | 19 cze 2025 | 20 cze 2025 | 02 lip 2025 |
| Income | 0,1872 € | 20 mar 2025 | 21 mar 2025 | 02 kwi 2025 |
| Income | 0,1542 € | 12 gru 2024 | 13 gru 2024 | 27 gru 2024 |
| Income | 0,1605 € | 12 wrz 2024 | 13 wrz 2024 | 25 wrz 2024 |
| Income | 0,7398 € | 13 cze 2024 | 14 cze 2024 | 26 cze 2024 |
| Income | 0,1452 € | 14 mar 2024 | 15 mar 2024 | 27 mar 2024 |
| Income | 0,1332 € | 14 gru 2023 | 15 gru 2023 | 27 gru 2023 |
Listed currencies: GBP, EUR, CHF, USD, MXN
Base currency: EUR
Exchanges: London Stock Exchange, NYSE Euronext - Amsterdam, SIX Swiss Exchange, Deutsche Boerse, Bolsa Mexicana De Valores, Borsa Italiana S.p.A.